Saba Capital Management Amends Filing for Infrastructure Fund

TL;DR

Saba Capital Management just updated their stake in MainStay CBRE Global Infrastructure Megatrends Term Fund. Watch this space.

AI Summary

Saba Capital Management, L.P. has filed an amendment (SC 13D/A) on March 26, 2024, regarding their holdings in MainStay CBRE Global Infrastructure Megatrends Term Fund. The filing indicates a change in their beneficial ownership, though specific new holdings or dollar amounts are not detailed in this excerpt. Saba Capital Management, L.P. is a significant investor in the fund.

Why It Matters

This amendment signals a potential shift in strategy or increased activity by Saba Capital Management concerning the MainStay CBRE Global Infrastructure Megatrends Term Fund, which could impact the fund's performance or governance.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D filings often precede significant corporate actions or changes in investor strategy, which can introduce volatility.

Key Players & Entities

• Saba Capital Management, L.P. (company) — Filing entity
• MainStay CBRE Global Infrastructure Megatrends Term Fund (company) — Subject company
• Michael D'Angelo (person) — Contact person for Saba Capital Management
• BOAZ R. WEINSTEIN (person) — Group member of Saba Capital Management
• SABA CAPITAL MANAGEMENT GP, LLC (company) — Group member of Saba Capital Management

FAQ

Key Financial Figures

• $0.001 — Fund (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securiti
• $73,020,285 — ported herein. A total of approximately $73,020,285 was paid to acquire the Common Shares r

Filing Documents

• formsc13da.htm (SC 13D/A) — 52KB
• 0001062993-24-007100.txt ( ) — 54KB

is hereby amended and supplemented as follows

Item 4 is hereby amended and supplemented as follows: On March 22, 2024, Saba Capital Master Fund, Ltd., a private fund advised by Saba Capital, submitted to the Issuer a notice of intent informing the Issuer of its intention to nominate Paul Kazarian (the " Nominee ") as an independent trustee for election at the Issuer's 2024 annual meeting of shareholders (the " Annual Meeting "). Item 5. INTEREST IN SECURITIES OF THE ISSUER (a) See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons. The percentages used herein are calculated based upon 52,047,534 shares of common stock outstanding as of 11/30/23, as disclosed in the company's N-CSRS filed 2/2/24. (b) See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. (c) The transactions in the Common Shares effected within the past sixty days by the Reporting Persons, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference. CUSIP No. 56064Q107 SCHEDULE 13D/A Page 6 of 8 Pages (d) The funds and accounts advised by Saba Capital have the right to receive the dividends from and proceeds of sales from the Common Shares. (e) Not applicable. CUSIP No. 56064Q107 SCHEDULE 13D/A Page 7 of 8 Pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: March 26, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 56064Q107 SCHEDULE 13D/A Page 8 of 8 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital during the past sixty days. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 3/19/2024 Buy 22,144 12.30

View Full Filing

View this SC 13D/A filing on SEC EDGAR